title: Evidence for a systemic defect of resistance-sized arterioles in hypertrophic cardiomyopathy.
abstract: BACKGROUND
  To investigate whether the abnormalities of coronary arterioles observed in association with hypertrophic cardiomyopathy represent a generalized phenomenon, both forearm and coronary vasodilator reserve were measured in 12 patients with hypertrophic cardiomyopathy.
  
  
  METHODS
  Forearm vasodilator reserve was evaluated by measuring minimal forearm vascular resistance (Rmin, the ratio of mean intra-arterial pressure to peak forearm blood flow measured by venous plethysmography) under conditions of maximal postocclusive reactive hyperemia.
  
  
  RESULTS
  In a subgroup (n = 5) of patients, the intra-arterial infusion of sodium nitroprusside combined with arterial occlusion did not produce additional vasodilation, indicating that the ischemic stimulus was indeed maximal. Coronary reserve was quantitated by measuring left ventricular blood flow (13N-ammonia and positron emission tomography) and coronary resistance at baseline and after intravenous dipyridamole (0.56 mg/kg). Rmin was significantly greater in patients than in a group of age- and sex-matched controls. The percentage change in coronary resistance after dipyridamole was significantly related to Rmin, whereas no correlation was found between change in coronary resistance and individual septal thickness values.
  
  
  CONCLUSIONS
  Independent of cardiac hypertrophy, systemic and coronary arterioles of patients with hypertrophic cardiomyopathy are affected by an abnormality that may contribute to the clinical evolution of this syndrome.
authors.affiliation: I Clinica Medica, University of Pisa, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Pedrinelli
authors.forename: M
authors.initials: M
authors.lastname: Spessot
authors.forename: G
authors.initials: G
authors.lastname: Chiriatti
authors.forename: R
authors.initials: R
authors.lastname: Gistri
authors.forename: P
authors.initials: P
authors.lastname: Salvadori
authors.forename: G
authors.initials: G
authors.lastname: Catapano
authors.forename: G
authors.initials: G
authors.lastname: Panarace
authors.forename: L
authors.initials: L
authors.lastname: Papi
authors.forename: A
authors.initials: A
authors.lastname: L'Abbate
authors.forename: P G
authors.initials: PG
authors.lastname: Camici
mesh_terms: D000328:Adult; D000368:Aged; D002306:Cardiac Volume / Q000187:drug effects / Q000502:physiology; D002312:Cardiomyopathy, Hypertrophic / Q000000981:diagnostic imaging / Q000503:physiopathology*; D003326:Coronary Circulation / Q000187:drug effects / Q000502:physiology*; D004176:Dipyridamole; D004452:Echocardiography / Q000187:drug effects; D005260:Female; D005542:Forearm / Q000098:blood supply; D006801:Humans; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000503:physiopathology*; D009599:Nitroprusside; D014655:Vascular Resistance / Q000187:drug effects / Q000502:physiology*; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology
chemical_list: D009599:Nitroprusside; D004176:Dipyridamole